MedPath

Somnitabs

HTE - 1019 - 2025-0520

Approved
Approval ID

0ce0cb28-5ea1-43e5-8da1-02128b9989a5

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 20, 2025

Manufacturers
FDA

HARRIS TEETER

DUNS: 047279351

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIPHENHYDRAMINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72036-019
Application NumberM010
Product Classification
M
Marketing Category
C200263
G
Generic Name
DIPHENHYDRAMINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateMay 20, 2025
FDA Product Classification

INGREDIENTS (7)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: L11K75P92J
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
DIPHENHYDRAMINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 1
Code: TC2D6JAD40
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 5/20/2025

PRINCIPAL DISPLAY PANEL

Harris Teeter™

Somnitabs

Compare to the Active Ingredient in Sominex®

Diphenhydramine HCl, 25 mg

NIGHTTIME SLEEP-AID

•Does NOT contain Pain Reliever

• Original Formula

32 TABLETS

image description

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 12/21/2012

Use

helps to reduce difficulty falling asleep

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 10/10/2019

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 12/21/2012

Active ingredient (in each tablet)

Diphenhydramine HCl 25 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 12/21/2012

Purpose

Nighttime sleep-aid

WARNINGS SECTION

LOINC: 34071-1Updated: 12/21/2012

Warnings

Do not use

  • in children under 12 years of age
  • with any other product containing diphenhydramine, even one used on skin

Ask a doctor before use if you have

  • glaucoma
  • a breathing problem such as emphysema or chronic bronchitis
  • trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you aretaking sedatives or tranquilizers

When using this productavoid alcoholic drinks

Stop use and ask a doctor ifsleeplessness persists continuously for more than 2 weeks. Insomnia may be a symptom of serious underlying medical illness.

**If pregnant or breast-feeding,**ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 12/21/2012

Directions

  • adults and children 12 years of age and over: take 2 tablets at bedtime if needed, or as directed by a doctor

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 12/21/2012

Other information

  • each tablet contains:calcium 85 mg
  • store at room temperature 15°-30°C (59°-86°F)
  • retain carton for complete product information

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 12/21/2012

Inactive ingredients

colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate, FD&C blue #1, magnesium stearate, microcrystalline cellulose

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 5/20/2025

Questions or comments?

1-844-705-4384

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Somnitabs - FDA Drug Approval Details